These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6326350

  • 1. Correlative morphological and biochemical studies on monocrotaline-induced pulmonary alterations in rats.
    Hayashi Y, Kokubo T, Takahashi M, Furukawa F, Otsuka H, Hashimoto K.
    Toxicol Lett; 1984 Apr; 21(1):65-71. PubMed ID: 6326350
    [Abstract] [Full Text] [Related]

  • 2. Increased alveolar-capillary membrane permeability by monocrotaline.
    Kido M, Hirose T, Tanaka K, Kurozumi T, Shoyama Y.
    Jpn J Med; 1981 Jul; 20(3):170-9. PubMed ID: 6803046
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
    Kay JM, Keane PM, Suyama KL, Gauthier D.
    Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
    [Abstract] [Full Text] [Related]

  • 4. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
    Molteni A, Ward WF, Ts'ao CH, Solliday NH.
    Proc Soc Exp Biol Med; 1986 Sep; 182(4):483-93. PubMed ID: 3016747
    [Abstract] [Full Text] [Related]

  • 5. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
    Molteni A, Ward WF, Ts'ao CH, Hinz JM.
    Biochem Pharmacol; 1989 Aug 01; 38(15):2411-9. PubMed ID: 2547380
    [Abstract] [Full Text] [Related]

  • 6. Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.
    Shale DJ, Wiseman MS, Cookson WO.
    Thorax; 1986 Dec 01; 41(12):914-8. PubMed ID: 3035737
    [Abstract] [Full Text] [Related]

  • 7. Monocrotaline-induced cardiopulmonary injury in rats: modification by thiol and nonthiol ACE inhibitors.
    Molteni A, Ward W, Ts'ao C, Solliday N.
    Clin Exp Hypertens A; 1987 Dec 01; 9(2-3):381-5. PubMed ID: 3038399
    [No Abstract] [Full Text] [Related]

  • 8. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
    Ito K, Nakashima T, Murakami K, Murakami T.
    Br J Pharmacol; 1988 Aug 01; 94(4):1175-83. PubMed ID: 3145089
    [Abstract] [Full Text] [Related]

  • 9. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
    Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA.
    Toxicol Appl Pharmacol; 1990 Nov 01; 106(2):179-200. PubMed ID: 2256110
    [Abstract] [Full Text] [Related]

  • 10. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline.
    Lafranconi WM, Huxtable RJ.
    Thorax; 1983 Apr 01; 38(4):307-9. PubMed ID: 6306859
    [Abstract] [Full Text] [Related]

  • 11. Monocrotaline pneumotoxicity in mice.
    Molteni A, Ward WF, Ts'ao CH, Solliday NH.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989 Apr 01; 57(3):149-55. PubMed ID: 2570481
    [Abstract] [Full Text] [Related]

  • 12. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617.
    Molteni A, Ward WF, Ts'ao C, Solliday NH.
    Arch Int Pharmacodyn Ther; 1988 Apr 01; 291():21-40. PubMed ID: 3129998
    [Abstract] [Full Text] [Related]

  • 13. Monocrotaline-induced pulmonary endothelial dysfunction in rats.
    Molteni A, Ward WF, Ts'ao CH, Port CD, Solliday NH.
    Proc Soc Exp Biol Med; 1984 May 01; 176(1):88-94. PubMed ID: 6324229
    [Abstract] [Full Text] [Related]

  • 14. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
    Lalich JL, Johnson WD, Raczniak TJ, Shumaker RC.
    Arch Pathol Lab Med; 1977 Feb 01; 101(2):69-73. PubMed ID: 138406
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul 01; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989 Jul 01; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 19. Monocrotaline-induced angiogenesis. Differences in the bronchial and pulmonary vasculature.
    Schraufnagel DE.
    Am J Pathol; 1990 Nov 01; 137(5):1083-90. PubMed ID: 1700616
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.